Table.
Measure | OFC (acq) | Sham (acq) | OFC (rev) | Sham (rev) |
---|---|---|---|---|
Rate CS+ 1st 5 s | 13.1 ± 3.3 | 17.5 ± 3.6 | 16.2 ± 4.3 | 22.1 ± 3.4 |
Rate CS+ 2nd 5 s | 18.0 ± 4.4 | 19.3 ± 4.8 | 20.0 ± 4.9 | 23.3 ± 3.5 |
Rate CS- 1st 5 s | 1.1 ± 0.5 | 1.5 ± 0.6 | 4.6 ± 1.1 | 5.1 ± 1.1 |
Rate CS- 2nd 5 s | 2.3 ± 0.8 | 2.4 ± 0.8 | 6.1 ± 1.4 | 6.9 ± 1.5 |
Percent trials CS+ 1st 5 s | 45.2 ± 7.5 | 57.7 ± 7.8 | 51.5 ± 8.3 | 72.8 ± 6.6 |
Percent trials CS+ 2nd 5 s | 55.1 ± 8.0 | 61.5 ± 8.8 | 57.0 ± 8.9 | 73.3 ± 5.8 |
Percent trials CS- 1st 5 s | 4.9 ± 1.8 | 7.0 ± 2.5 | 20.2 ± 4.0 | 19.2 ± 3.3 |
Percent trials CS- 2nd 5 s | 10.0 ± 2.9 | 9.5 ± 2.5 | 23.5 ± 4.2 | 24.2 ± 3.1 |
Notes. Rate = lever presses/min over all trials; % trials = percentage of trials on which at least one lever press response occurred; OFC = orbitofrontal cortex; acq = acquisition phase (sessions A1-A12); rev = reversal phase (sessions R1-R12). Entries are mean ± SEM, averaged over all sessions of each phase.